|
|
|
|
Science Sparks @ ACTREC
|
 13 April 2026 |
Vol. No. 15 ; Issue No.730 |
|
|
Publications
|
|
1. Patkar S, Shah TM, Kazi M, Kannan S, Varty G, Ostwal V, Ramaswamy A, Bhargav P, Barve P, Goel M(2026). Development and validation of nomogram predicting survival in resectable gallbladder cancer. Journal of Hepato-Biliary-Pancreatic Sciences
2. Prakash D, Agrawal A, Trivedi B, Venkatachalam M, Paunikar S, Kumar M, Chauhan H, Vajarkar V, Mitra S, Naik S, Ittiachan J, Khairnar K, Vijay V, Rafeeq R (2026). Code blue response in radionuclide therapy wards: A standard operating procedure for emergency care and radiation safety. Indian Journal of Nuclear Medicine. 41:61-77.
3. Roy A, Jain N, Pokale R, Madhusoodanan G, Mukharya A, Farhana S, Rao, B Goda JS, Mutalik S (2026). Synergizing immunity: lipid nanoparticle-mediated mRNA and gene delivery as a next-gen paradigm in cancer immunotherapy, International Journal of Pharmaceutics,
4. Valle L, Romero-Kalbasi T, Jiang T, van Dams R, Fuller D, Loblaw A, Kennedy T, Collins S, Sharma V, Suy S, Murthy V, Mallick I, Nickols N, Desai N, Hannan R, Aghdam N, Kaplan I, Stephans K, Tendulkar R, Lau S, Taparra K, Steinberg M, Kishan A (2026). Extended fllow-up from the stereotactic body radiotherapy for high-risk localized carcinoma of the prostate (SHARP) consortium: Updated analysis of 440 patients. European Urology Oncology,
|
|
|
|
|
Interesting Reads
|
|
Gay F, Roeloffzen W, Dimopoulos MA, Rosiñol L, van der Klift M, Mina R, Oriol A, Katodritou E, Wu KL, Rodríguez Otero P, Hájek R, Antonioli E, van Duin M, D'Agostino M, Martínez-López J, van Leeuwen-Segarceanu EM, Zamagni E, van de Donk NWCJ, Weisel KC, Pour L, Radocha J, Belotti A, Schjesvold F, Bladé J, Einsele H, Sonneveld P, Boccadoro M, Broijl A (2026). Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial. Nature Medicine.
|
|
|
Video of the Week
|
|
| Advancing Treatment for Neuroblastoma Through Collaboration: A Pediatric Oncology Paradigm |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 1996, the FDA approved anastrozole (Arimidex) as a treatment for breast cancer. This drug blocks the production of estrogen.
|
|
|
|
Cancer News
|
| |
|
AI-powered chemistry accelerates discovery of selective cancer inhibitors.
|
|
News-Medical, 09/04/2026
|
|
The core innovation of this work lies in the clever exploitation of noncovalent interactions. Through a conformational restriction strategy, the molecular spatial geometry is precisely controlled while hydrogen‑bond donors that could adversely affect physicochemical properties are effectively masked...
|
| |
|
Long non-coding RNA may be a promising therapeutic target for cancer.
|
|
MedicalXpress, 09/04/2026
|
|
In the current study, the scientists aimed to uncover cellular interactions between super enhancers clusters of regulatory DNA elements that drive high levels of transcription and lncRNAs by studying RNA sequencing data from patients with metastatic castration-resistant prostate cancer...
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
2026 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
